News for Pulse Biosciences, Inc. (PLSE)

Summary Pulse Biosciences Inc (PLSE), a pioneering company in bioelectric medicine, announced its participation in the TD Cowen 45th Annual Health Care Conferen

Colorado-based Aclarion, Inc. (ACON) is up over 30 percent in Tuesday's pre-market trading. The following are some of the other stocks making big moves in Tuesday's pre-market trading.

Colorado-based Aclarion, Inc. (ACON) is up over 30 percent in Tuesday's pre-market trading. The following are some of the other stocks making big moves in Tuesday's pre-market trading.

Summary Pulse Biosciences Inc (PLSE), a leader in bioelectric medicine, announced significant findings from its first-in-human feasibility study of the Nanoseco

Summary Pulse Biosciences Inc (PLSE), a leader in bioelectric medicine, announced that its cutting-edge Nanosecond Pulsed Field Ablationâ„¢ (nsPFAâ„¢) technolog

Summary Pulse Biosciences Inc (PLSE), a company specializing in Nanosecond Pulsed Field Ablationâ„¢ technology, announced the appointment of Paul A. LaViolette

Pulse Biosciences, Inc. (Nasdaq: PLSE) (the ”œCompany” or ”œPulse Biosciences”), a company leveraging its novel and proprietary Nanosecond Pulsed Field A

Summary Pulse Biosciences Inc (PLSE), a pioneering company in bioelectric medicine, announced its participation in the 43rd Annual J.P. Morgan Healthcare Confer

Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablationâ„¢ (nano-PFA or nsPFAâ„¢) technology, t

Pulse Biosciences' Nano-Pulse Stimulation technology has indications in several complex medical disorders. Read why I reiterate PLSE stock is a Hold.

Summary Pulse Biosciences Inc (PLSE), a leader in bioelectric medicine, has announced its intention to redeem the first tranche of common stock warrants on Dece

Tuesday's Insider Activity: Top Buys and Sells in US Stocks Revealed

Summary Pulse Biosciences Inc (PLSE), a company specializing in bioelectric medicine, has announced a significant advancement in cardiac surgery technology with

Pulse Biosciences director Robert Duggan buys $972,343 in stock

The stock of Jin Medical International Ltd (ZJYL) experienced significant volatility, plunging 5.37%. It is currently trading at $1.85 per share with a trading

Total GAAP Costs and Expenses: Increased by $2.4 million to $13.7 million compared to $11.3 million in the prior year period.Non-GAAP Costs and Expenses: Incre

Oct 30, 2024 / 08:30PM GMTOperator Greetings and welcome to the Pulse Biosciences third quarter, 2024 financial results conference call. (Operator Instructions)

The week saw FDA reprimanding a pharma giant for making false and misleading claims about its non-small cell lung cancer drug and a developer of MDMA therapy for PTSD facing a major setback.

This is our list of the best health care stocks based on the highest return over the last 30 days.